GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (XSWX:COLOB) » Definitions » Cyclically Adjusted PB Ratio

Coloplast A/S (XSWX:COLOB) Cyclically Adjusted PB Ratio : (As of Jun. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PB Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.49 37.39 35.32 24.27 22.77

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 27.01 22.77 23.07 26.70

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PB Ratio falls into.



Coloplast A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.884/118.4000*118.4000
=9.884

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 4.206 99.700 4.995
201409 4.841 99.700 5.749
201412 4.141 99.400 4.933
201503 4.368 100.200 5.161
201506 3.844 100.300 4.538
201509 3.259 100.200 3.851
201512 2.766 99.800 3.282
201603 3.393 100.200 4.009
201606 3.111 100.600 3.661
201609 3.509 100.200 4.146
201612 2.869 100.300 3.387
201703 3.437 101.200 4.021
201706 3.413 101.200 3.993
201709 4.323 101.800 5.028
201712 3.481 101.300 4.069
201803 3.979 101.700 4.632
201806 3.811 102.300 4.411
201809 4.577 102.400 5.292
201812 3.696 102.100 4.286
201903 4.400 102.900 5.063
201906 4.184 102.900 4.814
201909 4.756 102.900 5.472
201912 3.745 102.900 4.309
202003 4.391 103.300 5.033
202006 4.297 103.200 4.930
202009 5.045 103.500 5.771
202012 3.936 103.400 4.507
202103 4.847 104.300 5.502
202106 4.788 105.000 5.399
202109 5.604 105.800 6.271
202112 4.221 106.600 4.688
202203 4.787 109.900 5.157
202206 4.722 113.600 4.922
202209 5.057 116.400 5.144
202212 3.690 115.900 3.770
202303 4.411 117.300 4.452
202306 4.005 116.400 4.074
202309 10.490 117.400 10.579
202312 9.014 116.700 9.145
202403 9.884 118.400 9.884

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (XSWX:COLOB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coloplast A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (XSWX:COLOB) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (XSWX:COLOB) Headlines

No Headlines